Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wem.2009.12.015DOI Listing

Publication Analysis

Top Keywords

antivenom vipera
4
vipera berus
4
berus bites--a
4
bites--a comment
4
antivenom
1
berus
1
bites--a
1
comment
1

Similar Publications

The Venom of : Proteomics, Neurotoxic Effect and Neutralization by Antivenom.

Vet Sci

November 2024

Department of Chemistry, Faculty of Veterinary Medicine, University of Belgrade, Bulevar Oslobođenja 18, 11000 Belgrade, Serbia.

Deep proteomic analyses identified, in total, 159 master proteins (with 1% FDR and 2 unique peptides) from 26 protein families in the venom of Data are available via ProteomeXchange with the identifier PXD056495. The relative abundance of PLA2s is 11.60% of the crude venom, of which 4.

View Article and Find Full Text PDF

Vipera berus (V. berus) bites are associated with high morbidity, including kidney injury, in dogs. Although antivenom is often used and perceived effective to treat this type of snakebite, it is costly and associated with adverse events and specific diagnostics for this type of snakebite are lacking.

View Article and Find Full Text PDF

Introduction: The VipGrade is a French electronic clinical tool that was created in 2022 to help frontline clinicians grade envenomations due to European spp. and decide whether to use specific immunotherapy. The aim of this study was to test VipGrade on a paediatric retrospective cohort (2001-2022) of cases of spp.

View Article and Find Full Text PDF

Introduction: Alternative in vitro tests that can be used instead of animal experiments are those that can most closely evaluate the biological activity of the drug of interest. For testing the potency of antivenom, these are the methods used to assess cytotoxicity. The aim of this study was to evaluate the most commonly used cytotoxicity methods for determining the protective potency of the antivenom Viekvin, which neutralizes Vipera ammodytes venom.

View Article and Find Full Text PDF
Article Synopsis
  • The Eastern Long-Nosed Viper is one of Europe's most venomous snakes, and this study investigates how its venom varies from neonate (young) to adult stages, particularly in terms of procoagulant effects on human plasma.
  • Findings show that neonate venom is more potent in activating blood-clotting factors compared to adult venom, challenging previous assumptions about venom effects based solely on adult specimens.
  • Although all tested antivenoms can neutralize both venom types, they are generally more effective against adult venom, highlighting the need for further research on clinical implications of the observed venom variations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!